Daniel Ives

Daniel Ives, co-founder of Shift Bioscience, discusses groundbreaking gene therapies aimed at reversing aging and explores how reprogramming can reset cellular age. Liz Parrish, founder of BioViva, shares her experience with unapproved gene therapies and advocates for faster access for terminal patients. Medical ethicist Arthur Caplan raises concerns about the moral implications of life extension, warning that longevity treatments could exacerbate inequality. They dive into the risks, motivations, and future potential of regenerative medicine.

Discussing the field of epigenetic aging and the potential for reversing biological aging through innovative techniques. Exploring the use of AI transformer models to accelerate research. Delving into gene therapy for cellular rejuvenation and the implications of longevity singularity on society and politics.